Serving leading biopharmaceutical companies globally:

Last Updated: January 28, 2020

DrugPatentWatch Database Preview

SYLATRON Drug Profile

See Plans and Pricing

« Back to Dashboard

Summary for Tradename: SYLATRON

Patents:	30
Applicants:	1
BLAs:	1
Suppliers: see list	1
Recent Clinical Trials:	See clinical trials for SYLATRON

Recent Clinical Trials for SYLATRON

Identify potential brand extensions & biosimilar entrants

Sponsor	Phase
Roswell Park Cancer Institute	Phase 2
Duke University	Phase 2
The Cleveland Clinic	Phase 2

See all SYLATRON clinical trials

Pharmacology for SYLATRON

Ingredient-type	Interferon Alfa-2b Interferon-alpha

Company Disclosures: US Patents for SYLATRON

These patents were extracted from company disclosures

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Schering	SYLATRON	peginterferon alfa-2b	VIAL	103949	009	2001-01-19	Start Trial	Schering Corporation (Kenilworth, NJ)	2015-11-02	RX	Orphan	company
Schering	SYLATRON	peginterferon alfa-2b	VIAL	103949	009	2001-01-19	Start Trial	Enzon, Inc. (Piscataway, NJ)	2013-11-10	RX	Orphan	company
Schering	SYLATRON	peginterferon alfa-2b	VIAL	103949	009	2001-01-19	Start Trial	Enzon, Inc. (Piscataway, NJ)	2013-11-10	RX	Orphan	company
Schering	SYLATRON	peginterferon alfa-2b	VIAL	103949	009	2001-01-19	Start Trial	Schering Corporation (Kenilworth, NJ)	2015-11-02	RX	Orphan	company
Schering	SYLATRON	peginterferon alfa-2b	VIAL	103949	009	2001-01-19	Start Trial	Schering Corporation (Kenilworth, NJ)	2018-03-26	RX	Orphan	company
Schering	SYLATRON	peginterferon alfa-2b	VIAL	103949	009	2001-01-19	Start Trial	Schering Corporation (Kenilworth, NJ)	2018-03-26	RX	Orphan	company
Schering	SYLATRON	peginterferon alfa-2b	VIAL	103949	009	2001-01-19	Start Trial	Hoffmann-La Roche Inc. (Nutley, NJ) Genentech, Inc. (South San Francisco, CA)	2019-11-19	RX	Orphan	company
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

Patent Text Search: US Patents for SYLATRON

These patents were identified by searching patent claims

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Schering	SYLATRON	peginterferon alfa-2b	VIAL	103949	009	2001-01-19	Start Trial	BAYER INTELLECTUAL PROPERTY GMBH (Monheim, DE)	2031-04-05	RX	Orphan	search
Schering	SYLATRON	peginterferon alfa-2b	VIAL	103949	009	2001-01-19	Start Trial	Abbott Laboratories (Abbott Park, IL)	2023-03-24	RX	Orphan	search
Schering	SYLATRON	peginterferon alfa-2b	VIAL	103949	009	2001-01-19	Start Trial	Intermune, Inc. (Brisbane, CA)	2025-03-08	RX	Orphan	search
Schering	SYLATRON	peginterferon alfa-2b	VIAL	103949	009	2001-01-19	Start Trial	Roche Palo Alto LLC (Palo Alto, CA)	2039-02-26	RX	Orphan	search
Schering	SYLATRON	peginterferon alfa-2b	VIAL	103949	009	2001-01-19	Start Trial	Intermune, Inc. (Brisbane, CA)	2025-03-08	RX	Orphan	search
Schering	SYLATRON	peginterferon alfa-2b	VIAL	103949	009	2001-01-19	Start Trial	IBC Pharmaceuticals, Inc. (Morris Plains, NJ)	2025-04-06	RX	Orphan	search
Schering	SYLATRON	peginterferon alfa-2b	VIAL	103949	009	2001-01-19	Start Trial	IBC Pharmaceuticals, Inc. (Morris Plains, NJ)	2025-04-06	RX	Orphan	search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patents for SYLATRON

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Hong Kong	1071576	Start Trial
Japan	6121419	Start Trial
Canada	2827076	Start Trial
European Patent Office	1874824	Start Trial
Israel	253494	Start Trial
Australia	2009233925	Start Trial
Japan	5577558	Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon

Dow

Medtronic

Mallinckrodt

Baxter

Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.